Skip to main content
Equibles
ALHC logo

ALHC · Alignment Healthcare, Inc.

Track ALHC — free

Use ALHC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$13.54 -0.01 (-0.04%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.75B
Shares
207.44M

ALHC metrics

82 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$13.54
Market cap
$2.75B

Price action

19 metrics
Price change (1W)
-0.6%
Price change (30D)
+1.2%
Price change (3M)
-11.9%
Price change (6M)
-26.6%
Price change (YTD)
-31.4%
Price change (1Y)
-16.9%
Trailing year
Price change (5Y)
-33.6%
52-week high
$24.56
52-week low
$12.78
Change from 52-week high
-44.9%
Change from 52-week low
+5.9%
Annualized volatility
61.7%
Beta
0.3
RSI (14D)
38.9
Price vs SMA 50
-21.4%
Price vs SMA 200
-28.3%
Avg volume (3M)
5.40M
Relative volume
1.0
Average dollar volume
$96.21M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
207.44M

Valuation

12 metrics
P / E (TTM)
67.7
Trailing earnings · reciprocal yield 1.5%
PEG ratio
0.5
EV / revenue
0.5×
reciprocal yield 192.7%
EV / EBITDA
27.5×
reciprocal yield 3.6%
EV / EBIT
43.2×
reciprocal yield 2.3%
P / sales
0.6×
reciprocal yield 166.3%
P / book
10.4
reciprocal yield 9.6%
FCF yield
6.4%
TTM · current market cap
Buyback yield
—
P / FCF
15.5
reciprocal yield 6.4%
P / operating cash flow
13.4
reciprocal yield 7.5%
Earnings yield
1.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.7×
reciprocal yield 133.9%
EV / revenue historical average (5Y)
0.9×
reciprocal yield 108.7%
EV / EBIT historical average (3Y)
419.0×
reciprocal yield 0.2%
EV / EBIT historical average (5Y)
419.0×
reciprocal yield 0.2%
EV / EBITDA historical average (3Y)
168.2×
reciprocal yield 0.6%
EV / EBITDA historical average (5Y)
168.2×
reciprocal yield 0.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
—
Operating margin
1.2%
Trailing 12 months
Net margin
0.9%
Gross profit (TTM)
—
Operating profit (TTM)
$55.00M
Net income (TTM)
$40.70M
Trailing 12 months
Diluted EPS (TTM)
$0.20
FCF margin
3.9%
Effective tax rate
-5.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.19

Growth

11 metrics
Revenue growth YoY
+31.6%
Year over year
Net income growth YoY
+133.4%
Revenue (TTM)
$4.58B
Trailing 12 months
EPS growth YoY
+142.9%
Shares change YoY
+2.6%
Year over year · more shares
Revenue CAGR (3Y)
+40.2%
Revenue CAGR (5Y)
+32.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
15.4%
Return on assets
3.2%
Debt / equity
1.2
Current ratio
1.7
EBITDA (TTM)
$86.50M
Free cash flow (TTM)
$177.51M
Quick ratio
1.7
Interest coverage
3.4
Net debt / EBITDA
-4.4
Return on invested capital
—
Trailing 12 months
Net cash
$377.65M
Latest balance sheet
Cash & equivalents
$693.45M
Total assets
$1.28B
Total debt
$324.06M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$205.55M
Capital expenditures (TTM)
$28.04M
R&D (TTM)
—
SG&A (TTM)
$487.92M
Stock compensation (TTM)
$61.53M
R&D / revenue
—
Stock compensation / revenue
1.3%

Ownership (13F)

3 metrics
13F filers
330
13F filer change QoQ
+35
Institutional ownership
108.0%

Short interest

3 metrics
Short interest
11.3%
Latest settlement · 3.6 days to cover
Days to cover
3.6d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$23.43M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1832466 CUSIP 01625V104 13F (30d) 245 filings 245 filers Visit website Investor relations